Atara Biotherapeutics (ATRA) Interest Coverage Ratio (2013 - 2026)
Atara Biotherapeutics (ATRA) posted Interest Coverage Ratio of 4.06 for Q1 2026, up 96.36% on a QoQ basis from 111.43 in Q4 2025, and down 143.3% year-over-year from 9.37 in Q1 2025.
Atara Biotherapeutics (ATRA) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Atara Biotherapeutics' Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 4.06 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 143.3% year-over-year to 4.06 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.88 (up 50.04% YoY) and the FY2025 annual result came in at 0.1, up 101.94% from the prior year.
- Interest Coverage Ratio was 4.06 for Q1 2026 at Atara Biotherapeutics, up from 111.43 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 9.37 in Q1 2025 and bottomed at 645.63 in Q4 2022.
- A 5-year average of 66.39 and a median of 12.0 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio tumbled 5562.65% — and 2025, when it jumped 219.8%.
- Atara Biotherapeutics' Interest Coverage Ratio stood at 645.63 in 2022, then jumped by 99.26% to 4.78 in 2023, then sank by 151.16% to 12.0 in 2024, then plunged by 828.7% to 111.43 in 2025, then jumped by 96.36% to 4.06 in 2026.
- Business Quant data shows ATRA's Interest Coverage Ratio at 4.06 in Q1 2026, 111.43 in Q4 2025, and 0.57 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | -4.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.06 |
| Dec 31, 2025 | -111.43 |
| Sep 30, 2025 | -0.57 |
| Jun 30, 2025 | 0.13 |
| Mar 31, 2025 | 9.37 |
| Dec 31, 2024 | -12.00 |
| Sep 30, 2024 | -18.39 |
| Jun 30, 2024 | -14.45 |
| Mar 31, 2024 | -7.83 |
| Dec 31, 2023 | -4.78 |
| Sep 30, 2023 | -49.90 |
| Jun 30, 2023 | -51.82 |
| Mar 31, 2023 | -56.15 |
| Dec 31, 2022 | -645.63 |
| Sep 30, 2022 | -0.88 |
| Jun 30, 2022 | -1.78 |
| Mar 31, 2022 | -158.38 |
| Dec 31, 2021 | -13,343.29 |
| Sep 30, 2021 | -3.66 |
| Jun 30, 2021 | -6.79 |